CCDC no.: 1540999The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
Source of materialFluconazole (C 13 H 12 F 2 N 6 O, 20 mg) was dissolved in a water and DMF (v:v = 4:1, 5 mL) solution. Then the solution was transferred to a Teflon-lined stainless vessel and heated to 313 K for 72 h. It was then cooled to room temperature at a rate of 1 K/h to afford colorless block crystals of the title compound in ca. 30% yield.
Experimental detailsH atoms bonded to aromatic and methylene C atoms were positioned geometrically (C-H = 0.93 and 0.97 Å, respectively) and included in the refinement as the riding-model, with U iso (H) = 1.2Ueq(C). Hydroxyl and water H atoms were refined as rigid groups with O-H = 0.82 Å that were allowed to rotate but not tip, with U iso (H) = 1.5Ueq(O).
CommentFluconazole (C 13 H 12 F 2 N 6 O), 2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)-propan-2-ol, a good antifungal agent, has been effectively applied in clinical treatment and also plays a great role in preventing the opportunistic fungal infections for HIV patients [4,5]. In order to enhance fluconazole's biomedical application, numberous research groups have been engaged in new polymorphs of fluconazole, which resulted in the formation of several polymorphs,